Monterey Bay Labs Overview
- Founded
-
2000
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
Monterey Bay Labs General Information
Description
Developer of an epidermal delivery platform intended to offer proprietary InoCyte system for dermatology and skin care. The company's platform commercializes enhancer suspensions that accelerate epidermal delivery, enabling clients to improve compliance with cosmetic products in a range of applications such as anti-aging, whitening, cellulite reduction, acne and hair regrowth.
Contact Information
Website
www.mbaylabs.com
Formerly Known As
Nanocyte
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 8 HaEshel Street
- Industrial Park (South)
- Caesarea 38900
- Israel
+972 00-000-0000
Monterey Bay Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Dec-2017 | 000 | Completed | Out of Business | ||
| 1. Early Stage VC | 01-Feb-2014 | 000 | 000 | Completed | Startup |
Monterey Bay Labs Patents
Monterey Bay Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-1956894-A2 | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent | Active | 19-Apr-2005 | 0000000000 | |
| EP-1956894-B1 | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent | Inactive | 19-Apr-2005 | 0000000000 | |
| EP-1956894-A4 | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent | Active | 19-Apr-2005 | 0000000000 | 0 |
| US-8834862-B2 | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent | Inactive | 19-Apr-2005 | 0000000000 | 00 |
| US-20060234203-A1 | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent | Active | 19-Apr-2005 | A61K9/0014 |
Monterey Bay Labs Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
